Medical News

RSS

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.

4 Dec 2009

Cyberonics' FDA-approved VNS Therapy to be featured at the AES meeting

Cyberonics, Inc. announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.

4 Dec 2009

Preclinical data of Curis' HSP 90 inhibitor published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that preclinical data related to CUDC-305, the company’s Heat Shock Protein (HSP) 90 inhibitor, was published online this week in Molecular Cancer Therapeutics.

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009

Orthofix International announces the launch of its FUSION Lateral OA Brace

Orthofix International announced today that its sports medicine division, BREG, has expanded its successful line of FUSION® functional knee braces by introducing the FUSION® Lateral OA Brace, which features an ultra-thin low-profile hinge designed for individuals suffering from lateral compartment osteoarthritis (OA).

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

IMF to stage presentation on multiple myeloma at ASH annual meeting

The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.

4 Dec 2009

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines.

4 Dec 2009

Watchdog group names Sen. Chuck Grassley as third 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Chuck Grassley (R-Iowa) its third "Insurance Puppet" in an online advertising campaign targeting Iowa and Washington, D.C.

4 Dec 2009

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

4 Dec 2009

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, was named as winner of the Emerging Life Sciences Company of the Year award, at the Eastern Technology Council’s 17th annual Enterprise Awards gala.

4 Dec 2009

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

Guardsman Scientific is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures.

4 Dec 2009

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

Amorfix Life Sciences extends private placement warrants

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today it will not accelerate the expiry of the private placement warrants that were issued on April 29, 2009 with a $1.00 exercise price.

4 Dec 2009

Bells on Bay St. inspires business leaders to register their consent for organ and tissue donation

Three hundred business leaders took time from the hustle and bustle of attending holiday gatherings and trying to find the perfect gift for loved ones, to reflect this morning upon the urgent need to make one other vital gift - registration of consent to be an organ and tissue donor.

4 Dec 2009

Action on climate change will save lives, according to Canadian health professionals

Canada's prime minister must put the health of the world's citizens at the centre of discussions at the upcoming UN climate summit, according to Canadian health professionals. Prime Minister Stephen Harper announced last week that he will join world leaders at the historic meeting in Copenhagen in December.

4 Dec 2009

Campaign for legislation to protect adult film industry performers

On Friday, a broad coalition of health groups will unveil a campaign to press for California legislation to protect adult film industry performers. The legislative push will be formally announced in conjunction with a strategy symposium for the effort being held Friday, December 4th at UCLA (Public Affairs Building, North Campus).

4 Dec 2009

HHS Secretary highlights the benefits of health insurance reform for businesses

HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.

4 Dec 2009

Public Campaign Action Fund names Sen. Joe Lieberman its second 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Joe Lieberman (I-Conn.) its second "Insurance Puppet" in an online advertising campaign targeting Connecticut and Washington, D.C.

4 Dec 2009

U.S. Court grants preliminary approval of $350M settlement in lawsuit against UnitedHealth Group

The American Medical Association (AMA) announced today that the United States District Court for the Southern District of New York has granted preliminary approval of the previously disclosed $350 million settlement that would resolve a class-action lawsuit against UnitedHealth Group.

4 Dec 2009

Medical News

Pfizer to present study findings from its expanded breast cancer portfolio

Cyberonics' FDA-approved VNS Therapy to be featured at the AES meeting

Preclinical data of Curis' HSP 90 inhibitor published

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Orthofix International announces the launch of its FUSION Lateral OA Brace

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

IMF to stage presentation on multiple myeloma at ASH annual meeting

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Watchdog group names Sen. Chuck Grassley as third 'Insurance Puppet'

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

FDA approves once-daily SEROQUEL XR Extended Release Tablets

Amorfix Life Sciences extends private placement warrants

Bells on Bay St. inspires business leaders to register their consent for organ and tissue donation

Action on climate change will save lives, according to Canadian health professionals

Campaign for legislation to protect adult film industry performers

HHS Secretary highlights the benefits of health insurance reform for businesses

Public Campaign Action Fund names Sen. Joe Lieberman its second 'Insurance Puppet'

U.S. Court grants preliminary approval of $350M settlement in lawsuit against UnitedHealth Group

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News